ERBB2 and breast cancer: Among the four different subtypes of breast cancer, miR-96 and miR-183 levels were higher in HER2-enriched breast cancers than other types; miR-182 was lower but miR-183 was higher in basal-like breast cancers than other types of breast cancer.